SKYCOVID19 Trademark

Trademark Overview


On Wednesday, October 14, 2020, a trademark application was filed for SKYCOVID19 with the United States Patent and Trademark Office. The USPTO has given the SKYCOVID19 trademark a serial number of 79301874. The federal status of this trademark filing is REGISTERED as of Tuesday, August 31, 2021. This trademark is owned by SK bioscience Co., Ltd.. The SKYCOVID19 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations for use in the treatment or prevention of Covid-19; drugs for medical purposes for use in the treatment or prevention of Covid-19; pharmaceuticals for use in the treatment or prevention of Covid-19; Vaccines, veterinary vaccines, viral vaccines, human vaccine preparations, vaccines against pneumococcal infections with all of the aforementioned for use in connection with the treatment or prevention of Covid-19; diagnostic reagents for medical use in connection with immunization against Covid-19; diagnostic agents for pharmaceutical use for diagnosing Covid-19; pharmaceutical products for the treatment of infectious diseases, namely, Covid-19; pharmaceutical products for the treatment of viral diseases, namely, Covid-19; antiviral preparations for use in the connection with the treatment or prevention of Covid-19; immunotherapeutic agents for medical use related to the treatment bacterial infections from Covid-19; bacterial preparations for medi...
skycovid19

General Information


Serial Number79301874
Word MarkSKYCOVID19
Filing DateWednesday, October 14, 2020
Status700 - REGISTERED
Status DateTuesday, August 31, 2021
Registration Number6465891
Registration DateTuesday, August 31, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations for use in the treatment or prevention of Covid-19; drugs for medical purposes for use in the treatment or prevention of Covid-19; pharmaceuticals for use in the treatment or prevention of Covid-19; Vaccines, veterinary vaccines, viral vaccines, human vaccine preparations, vaccines against pneumococcal infections with all of the aforementioned for use in connection with the treatment or prevention of Covid-19; diagnostic reagents for medical use in connection with immunization against Covid-19; diagnostic agents for pharmaceutical use for diagnosing Covid-19; pharmaceutical products for the treatment of infectious diseases, namely, Covid-19; pharmaceutical products for the treatment of viral diseases, namely, Covid-19; antiviral preparations for use in the connection with the treatment or prevention of Covid-19; immunotherapeutic agents for medical use related to the treatment bacterial infections from Covid-19; bacterial preparations for medical purposes for use in connection with the treatment of condition related to Covid-19; reagents for use in diagnostic tests for medical purposes for purposes of diagnosing Covid-19 infections; sterilizing washes for use in preventing the transmission of Covid-19; disinfectants for chemical toilets for use in preventing the transmission of Covid-19; medical diagnostic test strips for use in connection with diagnosing Covid-19 infections
Pseudo MarkSKY COVID ONE NINE; SKY COVID NINETEEN

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSK bioscience Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSK bioscience Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSK bioscience Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, March 7, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 10, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 10, 2022FINAL DISPOSITION PROCESSED
Tuesday, November 30, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 31, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 25, 2021REFUSAL PROCESSED BY IB
Monday, April 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 5, 2021REFUSAL PROCESSED BY MPU
Tuesday, March 30, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 29, 2021NON-FINAL ACTION WRITTEN
Wednesday, March 24, 2021ASSIGNED TO EXAMINER
Monday, March 15, 2021ASSIGNED TO EXAMINER
Monday, March 15, 2021ASSIGNED TO EXAMINER
Tuesday, January 12, 2021APPLICATION FILING RECEIPT MAILED
Friday, January 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 7, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB